Table 1.

Baseline Clinicopathological Features in 109 Gastric Cancer Patients.

Characteristics	No. of patients (%)	Characteristics	No. of patients (%)
Age group		Lymph node status
<30	1 (0.9)	Negative	40 (36.7)
30-39	11 (10.1)	1-2 positive node(s)	42 (38.5)
40-49	12 (11.0)	3-6 positive nodes	17 (15.6)
50-59	40 (36.7)	7-15 positive nodes	9 (8.3)
≥60	45 (41.3)	> 15 positive nodes	1 (0.9)
Sex		LVI
Male	68 (62.4)	Present	42 (38.5)
Female	41 (37.6)	Perineural invasion
		Present	41 (37.6)
Tumor location		Invasive depth
Antrum	87 (79.8)	T1	1 (0.9)
Antrum—Lesser curvature	7 (6.4)	T2	18 (16.5)
Fundus/Corpus	5 (4.6)	T3	16 (14.7)
Corpus—Lesser curvature	3 (2.8)	T4a	50 (45.9)
Cardia	3 (2.8)	T4b	24 (22.0)
Pyloric Antrum	3 (2.8)
Unknown	1 (0.9)
Histopathological type		pTNM Stage
Adenocarcinoma, NOS	86 (78.9)	I	3 (2.8)
Signet ring cell	16 (14.7)	IIA	24 (22.0)
Mucinous	7 (6.4)	IIB	24 (22.0)
		IIIA	21 (19.3)
		IIIB	26 (23.9)
		IIIC	11 (10.1)
Differentiated grade		Tumor budding
Well-differentiated	7 (8.1)	Grade I	25 (22.9)
Moderately-differentiated	36 (41.9)	Grade II	34 (31.2)
Poorly-differentiated	43 (50.0)	Grade III	50 (45.9)
Lauren classification		Relapse
Intestinal type	93 (85.3)	Present	31 (28.4)
Diffuse type	16 (14.7)	Recurrent pattern	21 (75.0)
		Distant metastasis